Carisma Therapeutics Announces Upcoming Presentation at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2024
Provided By PR Newswire
Last update: Aug 6, 2024
PHILADELPHIA, Aug. 6, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced its upcoming poster presentation at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2024, taking place in San Diego, California, November 15 – 19, 2024.
Read more at prnewswire.comNASDAQ:CARM (5/8/2025, 11:08:05 AM)
0.21
0 (0%)
Find more stocks in the Stock Screener
CARM Latest News and Analysis
6 days ago - ChartmillWondering what's happening in today's after-hours session?After the conclusion of the US market's regular session on Friday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
